MyAverix Finance
TWO · Healthcare
Tien Liang BioTech Co., Ltd. (4127)
Drug Manufacturers - Specialty & Generic
Tien Liang BioTech Co., Ltd. (4127) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4127
Tien Liang BioTech Co., Ltd. (4127) — FAQ
What is 4127's P/E ratio?
The price-to-earnings (P/E) ratio for Tien Liang BioTech Co., Ltd. (4127) is 18.00 (data as of 2026-05-23).
Does Tien Liang BioTech Co., Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Tien Liang BioTech Co., Ltd. (4127). Check the MyAverix Finance app for the latest dividend data.
What sector is Tien Liang BioTech Co., Ltd. in?
Tien Liang BioTech Co., Ltd. (4127) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4127 listed on?
4127 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.